Загрузка...
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells
While treatment for B-cell malignancies has been revolutionized through the advent of CAR immunotherapy, similar strategies for T-cell malignancies have been limited. Additionally, T-cell leukemias and lymphomas can commonly metastasize to the CNS, where outcomes are poor and treatment options are a...
Сохранить в:
| Опубликовано в: : | Stem Cell Rev Rep |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036178/ https://ncbi.nlm.nih.gov/pubmed/33410096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12015-020-10092-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|